GRAL Grifal S.p.A.

0.5750EUR0.00%Mkt Cap: 7.11M $P/E: —

Grifal S.p.A. provides packaging solutions in Italy, rest of Europe, and internationally. It offers corrugated cardboard packaging; cushion paper packaging, including cushion paper wrap, thermal, bottles, boxes, profiles…

HeadlineSourceTime
Older
la Repubblica
Teleborsa
Borsa Italiana
Borsa Italiana
MarketScreener Italia
Grail’s Multi-Cancer Blood Test Gets FDA Committee Vote for Premarket Approval

Grail received a favorable vote from a Food and Drug Administration panel regarding premarket approval for its Galleri multi-cancer early detection test. The cancer-detection company said the FDA’s medical devices advisory committee voted 7-2, with one abstention, to greenlight a premarket approval application for Galleri. The FDA isn’t bound to the committee’s recommendation, but it takes them into consideration when making the final regulatory decision.

The Wall Street Journal
With Approval Looking Likely, How Fast Will Sales of Cancer-Screening Blood Tests Rise?

Grail stock rose 35% this week as the Food and Drug Administration considers the company’s cancer blood test.

Barrons.com
Grail Stock Soars 34% Ahead of Multi-Cancer Blood Test Review From FDA

The biotech meets with the Food and Drug Administration this week for premarket approval of its landmark cancer blood test.

Barrons.com
SoldiOnline.it
Barrons.com
la Repubblica
soldionline.it
Corriere Bergamo